PSURs on APIs in Nationally Authorized Medicines Only Now Subject to EMA Centralized Assessment

Drug Industry Daily
Starting this month, active substances found only in medicines authorized at the country level in the EU are subject to centralized review of period safety update reports by the European Medicines Agency.

To View This Article:


Subscribe To Drug Industry Daily